Fate Therapeutics (FATE)'s 30-day implied volatility (IV30) was 77.5% at the close on November 4, 2026, down from 79.3% the day before, against a 52-week range of 57.7% to 157.5%. Its 20-day historical volatility was 71.4%.
Data as of November 4, 2026.